Loading
AP
Ayala Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Israel Biotech Fund I, L.P., was filed 31 Oct 2023.
Ayala Pharmaceuticals, Inc.: what insiders have been doing
Ayala Pharmaceuticals, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Ayala Pharmaceuticals, Inc. The previous disclosure was published on 12 February 2024.
The full history, which starts in 2020, counts 14 purchases against 7 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
47
Thresholds
n/a
Buy Volume
€22M
14 ops. · all time
Sell Volume
€847,083
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended October 2022 · cache
Income statement
Revenue222.6k
Gross profit80.1k36% margin
Net income-42.8M-19228.8% margin
Last declaration on 12 February 2024
Declarations47 total
4,237,687 shares@ US$0.408.0% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:1
3,887,438 shares@ US$0.407.4% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:2
1,295,813 shares@ US$0.402.5% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:3
8,437,500 shares@ US$0.4016.0% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:4
2,707,581 shares@ US$1.246516.0% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:5
8,062,500 shares@ US$0.4015.3% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:6
2,586,905 shares@ US$1.246515.3% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:7
1,926,221 shares@ US$0.40100.0% of flowCommon Stock, par value $0.001 per shareSEC:0001178913-24-000480:0
658,858 shares0Common Stock, par value $0.001 per shareSEC:0001178913-23-003462:0
Canonical exit: 16 Jan 2024 (T+90)
658,858 shares0Common Stock, par value $0.001 per shareSEC:0001178913-23-003462:1
Canonical exit: 16 Jan 2024 (T+90)
00Common StockSEC:0001178913-23-003362:0
46 sharesCommon StockSEC:0001493152-23-002246:0
120,000 shares0Common StockSEC:0000899243-22-018133:0
50,000 shares0Common StockSEC:0000899243-22-018135:0
50,000 shares0Common StockSEC:0000899243-22-018134:0
200 shares@ US$15.2783.0% of flowCommon StockSEC:0000899243-21-010346:0
Canonical exit: 6 Aug 2020 (T+90)
25 shares@ US$15.0210.2% of flowCommon StockSEC:0000899243-21-010346:1
Canonical exit: 10 Aug 2020 (T+90)
1 shares@ US$9.600.3% of flowCommon StockSEC:0000899243-21-010346:2
Canonical exit: 5 Oct 2020 (T+90)
4 shares@ US$11.861.2% of flowCommon StockSEC:0000899243-21-010346:3
Canonical exit: 15 Oct 2020 (T+90)
5 shares@ US$11.071.4% of flowCommon StockSEC:0000899243-21-010346:4
Canonical exit: 12 Nov 2020 (T+90)
10 shares@ US$10.072.5% of flowCommon StockSEC:0000899243-21-010346:5
Canonical exit: 10 Dec 2020 (T+90)
1 shares@ US$10.700.3% of flowCommon StockSEC:0000899243-21-010346:6
Canonical exit: 13 Dec 2020 (T+90)
4 shares@ US$11.561.1% of flowCommon StockSEC:0000899243-21-010346:7
Canonical exit: 23 Mar 2021 (T+90)
3,000 shares@ US$5.1612.0% of flowCommon StockSEC:0000899243-21-008447:0
3,000 shares@ US$17.4640.8% of flowCommon StockSEC:0000899243-21-008447:1
25 of 47 declarations
About Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for rare cancers and genetic diseases. It is listed on NASDAQ under the symbol AYLA.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
